NCT00035204View on ClinicalTrials.gov

A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

Not specified

Study Completion Date

May 31, 2003

Conditions
Alzheimer Disease
Interventions
DRUG

galantamine

All Listed Sponsors
collaborator

Ortho-McNeil Neurologics, Inc.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00035204 - A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease | Biotech Hunter | Biotech Hunter